Daily Cosmetic Research Analysis
Three papers stood out today: a randomized trial showing durable chin retrusion correction with a hyaluronic acid filler (VYC-25L), a PRISMA-conformant meta-analysis indicating sunscreen use may impair 25(OH)D levels, and a mechanistic biomaterials study revealing how low-density electrospun fibers enhance fibroblast mechanotransduction and matrix remodeling. Together, they span aesthetic outcomes, preventive dermatology, and regenerative scaffold design.
Summary
Three papers stood out today: a randomized trial showing durable chin retrusion correction with a hyaluronic acid filler (VYC-25L), a PRISMA-conformant meta-analysis indicating sunscreen use may impair 25(OH)D levels, and a mechanistic biomaterials study revealing how low-density electrospun fibers enhance fibroblast mechanotransduction and matrix remodeling. Together, they span aesthetic outcomes, preventive dermatology, and regenerative scaffold design.
Research Themes
- Aesthetic injectables and facial contouring outcomes
- Photoprotection versus vitamin D sufficiency
- Mechanotransduction-guided design of biomimetic scaffolds
Selected Articles
1. Low-density electrospun fibrous network promotes mechanotransduction and matrix remodeling in fibroblasts.
Using a low-density electrospun fiber network, the authors show that fibroblasts adopt a contractile, matrix-remodeling phenotype with upregulation of ECM-related transcripts and proteins. Mechanistically, RhoA-ROCK signaling, YAP nuclear translocation, and Piezo1 activation drive enhanced mechanotransduction; ROCK inhibition abrogated remodeling capacity.
Impact: This work elucidates micro-mechanical design principles for fibrous scaffolds that can actively program fibroblast behavior, informing regenerative and aesthetic tissue engineering.
Clinical Implications: Designing low-density, compliant fibrous scaffolds may enhance dermal matrix remodeling for wound healing and aesthetic skin regeneration (e.g., scar modulation, anti-aging).
Key Findings
- Low-density electrospun networks induced a contractile fibroblast phenotype with increased ECM-related gene and protein expression.
- RhoA-ROCK pathway activation, YAP nuclear translocation, and Piezo1 activation mediated enhanced mechanotransduction.
- ROCK inhibition disrupted mechanotransduction and impaired matrix-remodeling capacity.
Methodological Strengths
- Engineered low-density fibrous network enabling micro-mechanical interrogation without confounding fiber entanglement
- Multi-level mechanistic readouts (transcriptional, protein-level, functional remodeling) with pharmacologic inhibition (ROCK) to test causality
Limitations
- In vitro study without in vivo validation of remodeling outcomes
- Limited quantitative characterization of network mechanical parameters across conditions
Future Directions: Validate scaffold-guided remodeling in vivo (skin/wound models) and map fiber density, stiffness, and architecture design space to optimize mechanotransduction.
The mechanical interactions between cells and fiber-dominated extracellular matrix (ECM) are crucial in regulating matrix-remodeling and cellular physiological processes. Electrospun fibers, as a type of biomimicking fibers, provide an ideal platform for engineering a variety of tissues in vitro. However, the mechanisms by which electrospun fibers promote cellular matrix-remodeling, particularly concerning the characteristic mechanical compliance in the fibers, remain inadequately understood due to the crossing and entanglement of electrospun ultrafine fibers in those densely packed fibrous mats. This study devised low-density fibrous network and mechanically sensitive fibroblasts to investigate how cells sense, respond to, and remodel the residing microenvironment at both cellular and molecular levels. The results showed that the fibroblasts cultured on the low-density fibrous network exhibited a contractile phenotype, as evidenced by the upregulated transcription and synthesis of ECM-related proteins as well as fiber recruitment capability, thereby displaying a greater capacity in matrix-remodeling. Analysis of mechanotransduction-related markers revealed that the RhoA-ROCK signaling pathway was activated in the low-density fibrous network-substrated fibroblasts.
2. VYC-25L Is Safe and Effective for Enhancing the Chin and Jawline by Correcting Chin Retrusion in Chinese Adults.
In a randomized, multicenter Phase 3 trial (n=148), VYC-25L significantly improved chin projection at 24 weeks versus no treatment (Δ G–Sn–Pog 2.97° vs 0.09°; P<.0001), with effects sustained to 52 weeks. Patient- and clinician-reported outcomes (CACRS, GAIS, FACE-Q) markedly favored VYC-25L, and safety was acceptable with mostly mild-to-moderate injection-site reactions.
Impact: Provides high-quality evidence supporting a long-lasting, non-surgical option for chin retrusion, likely informing aesthetic practice and patient counseling.
Clinical Implications: VYC-25L can be considered for chin retrusion correction with expected 1-year durability, measurable anthropometric gains, and favorable patient satisfaction; monitor for common, mild-to-moderate ISRs.
Key Findings
- Primary endpoint met: mean Δ G–Sn–Pog angle at Week 24 was 2.97° (VYC-25L) vs 0.09° (control), P<.0001; improvement maintained to Week 52.
- Responder rates favored VYC-25L for CACRS (78.7% vs 18.8%) and GAIS (92.6% vs 4.2%); FACE-Q Satisfaction with Chin score higher (70.4 vs 34.9).
- Safety acceptable with low procedural pain (mean 2.6/10) and mostly mild-to-moderate injection-site reactions.
Methodological Strengths
- Randomized, multicenter Phase 3 design with clinical trial registration (NCT04559984)
- Objective anthropometric primary endpoint with patient- and clinician-reported secondary outcomes
Limitations
- Comparator was no-treatment rather than a sham or active control, with likely unblinded assessments
- Generalizability may be limited to Chinese adults with moderate-to-severe chin retrusion
Future Directions: Head-to-head trials versus alternative fillers or implants, blinded assessments, and expanded populations to assess generalizability and long-term safety.
BACKGROUND: Individuals with chin retrusion may seek chin and lower jawline aesthetic enhancement. OBJECTIVES: To evaluate VYC-25L (Juvéderm Volux XC; Allergan Aesthetics, an AbbVie company), a lidocaine-containing injectable hyaluronic acid dermal filler, for chin retrusion correction. METHODS: In this prospective, Phase 3, multicenter study (NCT04559984), Chinese adults with moderate-to-severe chin retrusion on the China (Allergan) Chin Retrusion Scale (CACRS) and glabella-subnasale-pogonion (G-Sn-Pog) angle <172.5° were randomized 2:1 to VYC-25L (treatment plus optional touch-up 4 weeks later) or no treatment (control). The primary endpoint was change from baseline (CFB) in G-Sn-Pog angle at Week 24. Secondary endpoints included CACRS response (≥1-point improvement), Global Aesthetic Improvement Scale (GAIS) response (improved/much improved), and FACE-Q Satisfaction with Chin score. Procedural pain was rated (0 = none to 10 = worst imaginable); injection-site responses (ISRs) were recorded daily for ≤28 days. RESULTS: The mean age of the patient (VYC-25L, n = 97; control, n = 51) was 31.2 years (range, 20-52 years). Mean CFB in G-Sn-Pog angle at Week 24 was 2.97° (VYC-25L) vs 0.09° (control; between-group difference, 3.08° [P < .0001]); improvement was maintained to Week 52. At Week 24, VYC-25L achieved higher responses vs control for CACRS (78.7% vs 18.8%, respectively; rate difference, 60.0%; P < .0001) and GAIS (92.6% vs 4.2%, respectively; rate difference, 88.4%; P < .0001); mean overall FACE-Q Satisfaction with Chin score was 70.4 vs 34.9, respectively. Mean (standard deviation) procedural pain was 2.6 (1.6); most ISRs were mild (41.8%) or moderate (50.0%) in severity. CONCLUSIONS: In Chinese adults, VYC-25L safely and effectively corrected chin retrusion for at least 1 year.
3. Sunscreen and 25-Hydroxyvitamin D Levels: Friends or Foes? A Systematic Review and Meta-Analysis.
Following PRISMA standards, this review synthesized 22 studies (7 meta-analyzed; n=9470) and found that sunscreen blocks UV-B in vitro and, overall, use may reduce 25(OH)D levels. Given heterogeneity across designs and exposures, results point to a potential trade-off between photoprotection and vitamin D sufficiency.
Impact: Clarifies a clinically relevant controversy with quantitative synthesis, informing balanced guidance on photoprotection and vitamin D monitoring.
Clinical Implications: For high sunscreen users or individuals at risk for deficiency, consider monitoring 25(OH)D and ensuring adequate intake via diet or supplements while maintaining photoprotection.
Key Findings
- Included 22 studies (7 in meta-analysis) totaling 9470 participants.
- In vitro evidence consistently shows sunscreen blocks UV-B needed for cutaneous vitamin D synthesis.
- Pooled clinical evidence supports that sunscreen use can impair 25(OH)D levels, amid study heterogeneity.
Methodological Strengths
- PRISMA-compliant systematic review across multiple databases with quantitative synthesis
- Large aggregated sample size enhancing generalizability
Limitations
- Substantial heterogeneity and limited number of studies included in meta-analysis
- Risk-of-bias tool (QUADAS-2) is tailored to diagnostic accuracy and may be suboptimal for intervention/exposure studies
Future Directions: Well-controlled longitudinal and randomized studies quantifying sunscreen application behaviors, UV exposure, and standardized 25(OH)D outcomes; evaluate mitigation strategies (dietary/supplemental vitamin D).
OBJECTIVE: To evaluate the impact of sunscreen use on 25-hydroxyvitamin D (25(OH)D) levels, addressing conflicting findings from observational and interventional studies. METHODS: Potentially eligible studies were identified from the PubMed/MEDLINE, Scopus, and Web of Science databases from inception to November 2024, utilizing a search strategy incorporating terms related to "sunscreen" and "vitamin D." The studies eligible addressed the questions define based on the Population, Intervention, Comparator, Outcome framework: What are 25(OH)D levels in patients exposing to sun applying or not sunscreen? This review followed Preferred Reported Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The quality assessment and the risk of bias were analyzed using Quality Assessment of Diagnostic Accuracy Studies version 2. RESULTS: We included 22 studies in the qualitative synthesis, and 7 in the quantitative one, encompassing a total of 9470 participants. In vitro studies consistently showed that sunscreen blocks UV-B radiation, crucial for vitamin D CONCLUSION: The existing evidence supports that sunscreen can impair vitamin D